“The Efficacy of Palivizumab Prophylaxis for Acute Respiratory Syncytial Virus Infections in At-Risk Populations: A Literature Review”. 2022. Revista Eletrônica Acervo Médico 17 (September): e10854. https://doi.org/10.25248/reamed.e10854.2022.